Masimo | MASI - Equity Capital And Reserves


Masimo reported $810M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Accuray USD 61.87M 19.3M Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
AngioDynamics USD 185.87M 898K Feb/2025
Artivion USD 438.69M 18.79M Sep/2025
AtriCure USD 491.94M 15.43M Dec/2025
Avanos Medical USD 778.2M 200K Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
Masimo USD 810M 232.8M Sep/2025
Medtronic USD 48.86B 964M Sep/2025
Orthofix International USD 442.49M 15.86M Sep/2025
Owens Minor USD -460.98M 31.47M Dec/2025
ResMed USD 6.32B 199.61M Dec/2025
Steris USD 7.15B 145.4M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.82B 421M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025